GRP
CRNX

Global Retirement Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Global Retirement Partners’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11K Buy
+190
New +$7.06K ﹤0.01% 3551
2024
Q4 		$358 Sell
7
-55
-89% -$3.08K ﹤0.01% 3451
2024
Q3 		$3.17K Sell
62
-197
-76% -$10.2K ﹤0.01% 2765
2024
Q2 		$11.6K Buy
+259
New +$12K ﹤0.01% 2249

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's CRNX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 190 shares worth $7.11K. The stake represents ﹤0.01% of the portfolio and ranks #3551 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CRNX as recently as Q4 2024.

Global Retirement Partners first reported a position in CRNX in Q2 2024 and has held it in 4 quarters since. The position peaked at $11.6K in Q2 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Global Retirement Partners held 190 shares of Crinetics Pharmaceuticals worth $7.11K as of Q2 2026.
  • Crinetics Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3551 holding.
  • Global Retirement Partners first reported a position in Crinetics Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Global Retirement Partners's Crinetics Pharmaceuticals position peaked at $11.6K in Q2 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.